This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ERx (Electronic Prescribing/e-Prescribing) Market By Hardware, Software, Services, End-users (Medical Group Practice & Hospitals), Products (Integrated & Standalone Systems) & Deployment (Licensed, Web-hosted & Cloud) - Global Forecasts To 2017

2010 – 2017 ($MILLION) 120

TABLE 69 APAC: HARDWARE E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 121

TABLE 70 APAC: SOFTWARE E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 122

TABLE 71 APAC: SERVICES E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 123

TABLE 72 APAC: ON–PREMISE E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 124

TABLE 73 APAC: WEB-HOSTED E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 125

TABLE 74 APAC: CLOUD E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 126

TABLE 75 APAC: PC-BASED E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 127

TABLE 76 APAC: HANDHELD E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 128

TABLE 77 APAC: HOSPITAL E-PRESCRIBING MARKET, BY COUNTRY,

2010 – 2017 ($MILLION) 129

TABLE 78 APAC: OFFICE-BASED PHYSICIAN E-PRESCRIBING MARKET,

BY COUNTRY, 2010 – 2017 ($MILLION) 130

TABLE 79 MERGERS & ACQUISITIONS, 2010 – 2012 134

TABLE 80 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/ JOINT VENTURES, 2010 – 2012 139

TABLE 81 NEW PRODUCT DEVELOPMENTS/PRODUCT MODIFICATION,

2010 – 2012 146

TABLE 82 OTHER STRATEGIES, 2010 – 2012 153

TABLE 83 ALLSCRIPTS: TOTAL REVENUE AND R&D EXPENDITURE,

2009 – 2011 ($MILLION) 158

TABLE 84 ALLSCRIPTS: TOTAL REVENUE, BY SEGMENT, 2009 – 2011 ($MILLION) 159

TABLE 85 ALLSCRIPTS: TOTAL REVENUE, BY GEOGRAPHY,

2009 – 2011 ($MILLION) 160

TABLE 86 ATHENAHEALTH: TOTAL REVENUE AND R&D EXPENDITURE,

2009 – 2011 ($MILLION) 165

TABLE 87 CERNER CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION) 173

TABLE 88 CERNER CORPORATION: TOTAL REVENUE, BY SEGMENT,

2009 – 2011 ($MILLION) 174

TABLE 89 CERNER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,

2009 – 2011 ($MILLION) 175

TABLE 90 EMDEON: TOTAL REVENUE, BY SEGMENT, 2008 – 2010 ($MILLION) 186

TABLE 91 HENRY SCHEIN: TOTAL REVENUE, BY SEGMENT,

2009 – 2011 ($MILLION) 199

TABLE 92 HENRY SCHEIN : TOTAL REVENUE, BY GEOGRAPHY,

2009 – 2011 ($MILLION) 199

8 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,461.16 +73.95 0.43%
S&P 500 2,032.74 +3.19 0.16%
NASDAQ 4,708.4770 +26.98 0.58%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs